High-dose cytarabine chemotherapy (≥4 g/m2/day) before allogeneic hematopoietic stem cell transplantation for non-core-binding-factor AML in the first complete remission-Reference-Cited by-同舟云学术

High-dose cytarabine chemotherapy (≥4 g/m2/day) before allogeneic hematopoietic stem cell transplantation for non-core-binding-factor AML in the first complete remission

Published:2020-08-17 Issue:13 Volume:61 Page:3128-3136
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Nagahata Yosuke¹,Kondo Tadakazu¹^ORCID,Ono Yuichiro²,Hiramoto Nobuhiro³,Kitano Toshiyuki¹,Hishizawa Masakatsu¹,Yamashita Kouhei¹,Hashimoto Hisako³,Ishikawa Takayuki²,Takaori-Kondo Akifumi¹

Affiliation:

1. Department of Hematology/Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

2. Department of Hematology, Kobe Medical Center General Hospital, Kobe, Japan

3. Department of Cell Therapy, Institute of Biomedical Research and Innovation, Kobe, Japan

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2020.1805112

Reference34 articles.

1. A comparative assessment of the curative potential of reduced intensity allografts in acute myeloid leukaemia

2. Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial

3. Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission

4. Impact of Pretransplantation Minimal Residual Disease, As Detected by Multiparametric Flow Cytometry, on Outcome of Myeloablative Hematopoietic Cell Transplantation for Acute Myeloid Leukemia

5. Prognostic and therapeutic implications of minimal residual disease at the time of transplantation in acute leukemia

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: From Dose Puzzle to Pharmacogenomic Biomarkers;Cancers;2021-02-25